Analyst consensus on ACN shifted lower this week. The average target price slipped to $246.78 from $249.19. The consulting giant carries a $115 billion market cap. Short interest sits at just 4.1% of free float, so bears are not piling in — but bulls are cooling off.
The medical device sector saw a wave of recommendation removals. Analysts pulled coverage from MDT, EW, ZBH, DXCM, ABT, and JNJ simultaneously. That kind of coordinated exit often signals a house reassigning coverage teams. BSX saw multiple individual changes on the same day, with its consensus buy count rising to 27 from 29 — still a broadly bullish picture.
On the upside, energy and gold names attracted upgrades. TRGP saw its target nudge up to $283.50. The midstream operator carries a $54.7 billion market cap. NEM also received a higher target at $143.05 as gold prices stay elevated. DVN joined the energy upgrade wave with a consensus target of $61.24.
The pattern is clear: analysts are rotating optimism from IT services into hard assets. Gold and energy names are gathering buy calls. Meanwhile, medtech coverage resets suggest structural changes inside sell-side research desks.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
